REFERENCES

1. Florio AA, Ferlay J, Znaor A, et al. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer 2020;126:2666-78.

2. Thinkhamrop K, Khuntikeo N, Phonjitt P, et al. Association between diabetes mellitus and fatty liver based on ultrasonography screening in the world's highest cholangiocarcinoma incidence region, Northeast Thailand. Asian Pac J Cancer Prev 2015;16:3931-6.

3. Shin HR, Oh JK, Masuyer E, et al. Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci 2010;101:579-85.

4. Lauterio A, De Carlis R, Centonze L, et al. Current surgical management of peri-hilar and intra-hepatic cholangiocarcinoma. Cancers 2021;13:3657.

5. Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 2014;60:1268-89.

6. Zhang H, Yang T, Wu M, Shen F. Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management. Cancer Lett 2016;379:198-205.

7. Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 2014;149:565-74.

8. Hyder O, Hatzaras I, Sotiropoulos GC, et al. Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery 2013;153:811-8.

9. Valle J, Wasan H, Palmer DH, et al; ABC-02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010;362:1273-81.

10. Rayar M, Levi Sandri GB, Houssel-Debry P, Camus C, Sulpice L, Boudjema K. Multimodal therapy including yttrium-90 radioembolization as a bridging therapy to liver transplantation for a huge and locally advanced intrahepatic cholangiocarcinoma. J Gastrointestin Liver Dis 2016;25:401-4.

11. Gadaleta-Caldarola G, Rizzo A, Dadduzio V, et al. Pemigatinib in intrahepatic cholangiocarcinoma: a work in progress. Curr Oncol 2022;29:7925-31.

12. Oh D, He AR, Qin S, et al. A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1. J Clin Oncol 2022;40:378.

13. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000;69:1633-7.

14. Casavilla FA, Marsh JW, Iwatsuki S, et al. Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 1997;185:429-36.

15. Sapisochin G, Facciuto M, Rubbia-Brandt L, et al; iCCA International Consortium. Liver transplantation for “very early” intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment. Hepatology 2016;64:1178-88.

16. McMillan RR, Javle M, Kodali S, et al. Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma. Am J Transplant 2022;22:823-32.

17. Rosen CB, Heimbach JK, Gores GJ. Liver transplantation for cholangiocarcinoma. Transpl Int 2010;23:692-7.

18. Lunsford KE, Javle M, Heyne K, et al; Methodist–MD Anderson Joint Cholangiocarcinoma Collaborative Committee (MMAJCCC). Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series. Lancet Gastroenterol Hepatol 2018;3:337-48.

19. Ito T, Butler JR, Noguchi D, et al. A 3-Decade, single-center experience of liver transplantation for cholangiocarcinoma: impact of era, tumor size, location, and neoadjuvant therapy. Liver Transpl 2022;28:386-96.

20. Mayo Clinc Liver transplant protocol for intrahepatic cholangiocarcinoma, Rochester , Minnesota.

21. Referenced with permission from the NCCN clinical practice guidelines in oncology (NCCN Guidelines®) for Biliary Tract Cancers V.2.2023. © National Comprehensive Cancer Network, Inc. 202X. Available from: https://www.nccn.org/professionals/physician_gls/pdf/btc.pdf [Last accessed on 14 Jul 2023].

22. Choi WJ, Ivanics T, Gravely A, Gallinger S, Sapisochin G, O'Kane GM. Optimizing circulating tumour DNA use in the perioperative setting for intrahepatic cholangiocarcinoma: diagnosis, screening, minimal residual disease detection and treatment response monitoring. Ann Surg Oncol 2023;30:3849-63.

23. Liver Transplantation for non- resectable intrahepatic cholangiocarcinoma: a prospective exploratory trial (TESLATrial). 2020. Available from: https://www.clinicaltrials.gov/ct2/show/record/NCT04556214 [Last accessed on 14 Jul 2023].

24. Liver transplantation for the treatment of early stages of intrahepatic cholangiocarcinoma in cirrhotics. 2016. Available from: https://clinicaltrials.gov/ct2/show/record/NCT02878473 [Last accessed on 14 Jul 2023].

25. Liver transplant for stable, advanced intrahepatic cholangiocarcinoma. 2019. Available from: https://clinicaltrials.gov/ct2/show/record/NCT04195503 [Last accessed on 14 Jul 2023].